Stopped reading about half way through as my eyes started to glaze......I'll come back to it.
This statement stared out at me.
"the acquisition will significantly increase the monthly recurring patient revenues for Respiri
from US$10-$20 to US$70-$100, reducing the number of patients required for the merged company monthly cash
break even to 9,000 which the company forecasts to achieve in late CY2024"
That's 18 months....I think I can hang in there.
Ann: RSH acquires US based Access RPM, capital raise and new NED, page-2
Add to My Watchlist
What is My Watchlist?
